Despite these limitations, the researchers believe the study confirmed the efficacy and safety of bimekizumab and brodalumab ...

Whether you suffer from psoriasis yourself or have heard about ... like not smoking tobacco. Before your next plaque surfaces and that unbearable tingle of an itch arises, you may find relief ...

A doctor has explained how to distinguish between a common skin condition that millions have and a more worrying contagious ...

That’s because certain genes play a role. Psoriasis is a skin disease that affects about 8 million Americans. It comes in several forms. Plaque psoriasis is the most common. Plaque psoriasis ...

QX004N, an interleukin-23 inhibitor, showed safety and efficacy in the treatment of moderate to severe plaque psoriasis, according to a study. QX004N, an IL-23 inhibitor, showed safety and ...

Guttate psoriasis may represent the initial stage of chronic plaque-type psoriasis. On resolution, post-inflammatory hypo or hyperpigmentation may result. There is no scarring. Patients should be ...

Share on Pinterest Super Bowl LIX champion Dallas Goedert of the Philadelphia Eagles shares his journey with plaque psoriasis, an autoimmune skin condition. Brooke Sutton/Getty Images Super Bowl ...

The company noted that the results further support the role of Sotyktu, the first TYK2 inhibitor available for patients living with moderate-to-severe plaque psoriasis, as a potential oral ...